PDCD1 and neoplasm: Despite this therapeutic success of immune therapies, drug resistance remains the most important obstacle to the achievement of durable outcomes since tumor cells evade the immune attack through PD-L1 expression in the cell membrane to block the PD-1/PD-L1 axis.